Status:
COMPLETED
Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions
Lead Sponsor:
Al-Azhar University
Conditions:
Macula Edema
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
The aim of this study is to compare formulated Posterior Subtenon Triamcinolone acetonide (PSTA) injection versus Posterior Subtenon Triamcinolone acetonide alone in the management of macular edema se...
Eligibility Criteria
Inclusion
- Diminution vision due to macular edema secondary to non-ischemic retinal vein occlusions, either central or branch, as evidenced by clinical and angiographic evaluation
- CMT ≥ 250 µ.
- Willing to participate in the study
Exclusion
- Unwilling to participate in the study.
- Ischemic RVO
- Prior laser treatment
- Glaucoma/Ocular Hypertension
- Cataract which lead to difficulty in the evaluation of macula
- Vitreous hemorrhage
- Macular ischemia
- Iris neovascularisation
- patients with intravitreal injection of anti VEGFs, steroid, or any intraocular surgery 3 months prior to the inclusion.
Key Trial Info
Start Date :
January 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 10 2022
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05385562
Start Date
January 2 2020
End Date
May 10 2022
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ehab tharwat
Damietta, New Damietta, Egypt, 34517